CHEST

Enhancing Future Research and Clarifying the Role of Minocycline in Refining Delirium Prevention in Critical Care
Xu S and Lu Z
Prophylactic Minocycline for Delirium With Unexpected Death Benefits: What Was Treated Unexpectedly?
Wang SY and Wei JC
Improving Diagnosis and Management of Pulmonary Hypertension in Interstitial Lung Disease
Hao L and Xue J
Are Lung Ultrasound B-Lines Better Than Pulmonary Function Tests in Predicting the Prognosis of Patients With Systemic Sclerosis?
Yakisik C, Azakli D and Satici C
Reflections on the Recent Study on Minocycline for Delirium Prevention in Patients in the ICU
Zhao X and Li C
Lung Nodules and Masses in non-HIV Immunocompromised Patients: A Clinical-Imaging Algorithmic Approach
Franquet T, Raoof S, Lee K, Han J, Gimenez A, Brenes J, Asmar J and Domingo P
The incidence of pulmonary nodules and masses in non-HIV immunocompromised patients has significantly increased due to advancements in hematopoietic stem cell transplantation (HSCT), solid organ transplantation (SOT), and the widespread use of chemotherapy and immunosuppressive therapies. Differentiating between infectious and non-infectious causes is critical for appropriate diagnosis and management, especially as radiological and clinical presentations can be nonspecific.
Effects of β-blockers on the Outcomes in Patients with Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: a Multicenter Prospective Cohort Study (BNP-PL)
Waligóra M, Kurzyna M, Mularek-Kubzdela T, Skoczylas I, Chrzanowski Ł, Błaszczak P, Jaguszewski M, Kuśmierczyk B, Ptaszyńska K, Grześk G, Mizia-Stec K, Malinowska E, Peregud-Pogorzelska M, Lewicka E, Tomaszewski M, Jacheć W, Florczyk M, Mroczek E, Gąsior Z, Pawlak A, Betkier-Lipińska K, Pruszczyk P, Widejko K, Zabłocka W and Kopeć G
The current guidelines do not recommend β-blockers in pulmonary arterial hypertension (PAH) unless indicated by comorbidities. However, the evidence regarding the role of β-blockers in PAH is contradictory.
The Determination of Brain Death
Nugent K and Berdine G
Quantitative Computed Tomography Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease
Humphries SM, Adegunsoye A, Demoruelle MK, Wei Kam ML, Amigues I, Bang TJ, Teague SD, Lynch DA, Chung JH, Strek ME, Swigris JJ and Solomon JJ
Quantitative chest computed tomography (CT) may be a useful predictor of outcome in rheumatoid arthritis-related interstitial lung disease (RA-ILD).
Clinical accuracy and risk of harm in asthma related content on TikTok
Murray JK, McNally E and Kent BD
Results of the SHARP Study: A Randomized, Placebo-Controlled, Double-Blind, Repeated-Measures, Crossover, Phase IV Clinical Trial of the Effect of the Wake-Promoting Agent Solriamfetol on Cognitive Function in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Cognitive Impairment
Van Dongen HPA, Leary EB, Drake C, Bogan R, Jaeger J, Rosenberg R, Streicher C and Tabuteau H
Obstructive sleep apnea (OSA) causes episodes of fragmented sleep and intermittent hypoxia and leads to excessive daytime sleepiness (EDS). Deficits in cognitive function are a troublesome symptom in patients with OSA and EDS.
Associations of socioeconomic status and phenotypic frailty with incident chronic obstructive pulmonary disease: findings from UK Biobank participants
Feng Z, Li G, He Q, Sun N, Li T, Han Q, Zhao H, Ma Z, Sun M, Liu B, Wang Y, Lou Z, Ma S, Shi Y, Li J, Sun Z, Jiang M and Shen Y
The independent, mediation, interaction, and joint effects of socioeconomic status (SES) and phenotypic frailty on the incidence of chronic obstructive pulmonary disease (COPD) are unclear.
Dietary pattern, sputum DNA methylation, and lung health: an epidemiological study in people who ever smoked
Feng Y, Kang H, Sood A, Guest DD, Fung TT, Rowe CL, Picchi MA, Pankratz VS, Belinsky SA and Leng S
We previously identified a panel of sputum DNA methylation that predicts lung ageing and risk for lung cancer.
Response
Sulmasy DP, DeCock CA, Tornatore CS, Roberts AH, Giordano J and Donovan GK
Sarcoidosis Treatment Patterns in the United States: 2016-2022
Sangani R, Bosch NA, Govender P, Scarpato B, Walkey AJ, Newman J, Law AC, Gillmeyer KR and Shankar DA
There are limited FDA-approved medications and real-world data on sarcoidosis treatment in the U.S. and concordance of practice patterns with guideline recommendations have not been well characterized.
Current Brain Death Clinical Criteria Are Adequate When Strictly Applied
DePietro M
Comparison of clinically meaningful improvements following center-based and home-based tele rehabilitation in people with COPD
Cox DNS, McDonald DC, Burge DAT, Hill DCJ, Bondarenko MJ and Holland PAE
Response to pulmonary rehabilitation is not equal for all participants, and may vary across health outcomes for any one individual. Alternative modes of pulmonary rehabilitation delivery, e.g. telerehabilitation, may improve program access but could also affect response to rehabilitation.
Response
Dal-Pizzol F and Ritter C
Response
Ang HL and Khor YH
Response
Wee LE, Tan JYJ, Chiew CJ, Abisheganaden JA, Chotirmall SH, Boon Lye DC and Tan KB
Pulmonary hypertension associated with Trastuzumab-Emtansine: an analysis of French PH registry and WHO pharmacovigilance database
Poisson C, Hlavaty A, Favrolt N, Chaumais MC, Grynblat J, Jutant EM, Lechartier B, Maurac A, Mouillot P, Palat S, Rambach L, Antigny F, Cottin V, Beltramo G, Humbert M, Khouri C, Bonniaud P and Montani D
Trastuzumab-emtansine have been recently suspected to be associated with the development of pulmonary arterial hypertension (PAH).